See the DrugPatentWatch profile for evomela
What is Evomela?
Evomela is the brand name for melphalan flufenamide, an anti-cancer medicine given by intravenous (IV) infusion. It is used in the treatment of certain multiple myeloma patients, typically in combination with other therapies [1].
What is it used for in cancer treatment?
Evomela is used for multiple myeloma, a cancer that affects plasma cells in the bone marrow [1].
How does Evomela work?
Melphalan flufenamide (Evomela) is a form of melphalan designed to deliver the drug into cancer cells. Once inside the body, it is converted into active melphalan, which helps kill rapidly dividing cancer cells [1].
How is Evomela given?
Evomela is administered as an IV infusion as part of a treatment regimen determined by the treating oncology team [1].
What side effects do people ask about?
Common questions with chemotherapy-like medicines include risks such as low blood counts (leading to infection or anemia) and GI side effects like nausea. The exact side effect profile and severity depend on the overall regimen and the patient’s condition [1].
---
Sources
[1] https://www.drugs.com/evomela.html